These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32820459)

  • 1. Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer's Disease.
    Uddin MS; Kabir MT; Tewari D; Al Mamun A; Barreto GE; Bungau SG; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    Mol Neurobiol; 2020 Dec; 57(12):4961-4977. PubMed ID: 32820459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenic Diet in Alzheimer's Disease.
    Rusek M; Pluta R; Ułamek-Kozioł M; Czuczwar SJ
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketone bodies as a therapeutic for Alzheimer's disease.
    Henderson ST
    Neurotherapeutics; 2008 Jul; 5(3):470-80. PubMed ID: 18625458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.
    Broom GM; Shaw IC; Rucklidge JJ
    Nutrition; 2019 Apr; 60():118-121. PubMed ID: 30554068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
    Kapogiannis D; Avgerinos KI
    Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ketogenic Diet and Alzheimer's Disease.
    Hersant H; Grossberg G
    J Nutr Health Aging; 2022; 26(6):606-614. PubMed ID: 35718870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
    Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet.
    Takeishi J; Tatewaki Y; Nakase T; Takano Y; Tomita N; Yamamoto S; Mutoh T; Taki Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    Xu Y; Zheng F; Zhong Q; Zhu Y
    J Alzheimers Dis; 2023; 92(4):1173-1198. PubMed ID: 37038820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease.
    Aso E; Semakova J; Joda L; Semak V; Halbaut L; Calpena A; Escolano C; Perales JC; Ferrer I
    Curr Alzheimer Res; 2013 Mar; 10(3):290-7. PubMed ID: 23131121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent fasting and Alzheimer's disease-Targeting ketone bodies as a potential strategy for brain energy rescue.
    Ye YC; Chai SF; Li XR; Wu MN; Cai HY; Wang ZJ
    Metab Brain Dis; 2024 Jan; 39(1):129-146. PubMed ID: 37823968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.
    Shinohara M; Sato N
    Adv Exp Med Biol; 2019; 1128():85-101. PubMed ID: 31062326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.
    Taylor MK; Swerdlow RH; Sullivan DK
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report.
    Horner S; Berger L; Gibas K
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101777. PubMed ID: 32305654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
    Hertz L; Chen Y; Waagepetersen HS
    J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.